Ceribell Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $102M+55.8% YoYTTM through 30 Jun 2026
Net Income -$66MTTM through 30 Jun 2026
Free Cash Flow -$54.7MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 88.0% |
| EBITDA Margin | -67.5% |
| Operating Margin | -65.5% |
| Net Margin | -64.7% |
Returns
-34.4%ROE
-27.3%ROA
Balance Sheet Health
Debt / Equity0.13x
Current Ratio9.73x
Net Debt-$139.3Mnet cash position
Cash & Equivalents$32.7M
Quality Metrics
Altman Z-Score12.74
Piotroski F-Score3 / 9
FCF Margin-53.7%
Rule of 40-41.9
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $89.1M
Diluted EPS-$1.76TTMFY2025: $-1.46
Dividend
No dividend
Capital Allocation
R&D Spend$23M
Capex Intensity0.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Product | $67.3M | +34.3% | |
| Subscription | $21.7M | +40.9% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.